Jonsson becomes COO at Nordic Nanovector
Plus: Aerie, Bio-Rad, Affinivax, Neogene, Orna and more
Oslo-based Nordic Nanovector ASA (OSE:NANOV) hired Sandra Jonsson as COO, effective Jan. 10, replacing Marco Renoldi who is retiring. Jonsson joins Nordic Nanovector from Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), where she was senior director of commercial international before its acquisition by AstraZeneca plc (LSE:AZN; NASDAQ:AZN). Previously, she was head of commercial strategy and operations in Europe at Shire, until it was acquired by Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) in 2019, and held several roles at Novartis AG (SIX:NOVN; NYSE:NVS) for 11 years.
Ophthalmic pharmaceutical company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) hired Raj Kannan as CEO and a board member, effective Dec. 20. Kannan was previously CEO and president of Chiasma Inc. (NASDAQ:CHMA), and CCO at Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA). Kannan replaces Vicente Anido, who left the company in September after disappointing Phase IIb data for dry eye therapy AR-15512...